Novo Nordisk Russia

Novo Nordisk Russia is owned by Novo Nordisk.

Novo Nordisk is one of the...

• Forbes Global 2000 (#284);
• Stoxx 600.

Novo Nordisk is a company listed under the stock ticker NOVO (DK).

Novo Nordisk has a direct presence in 12 countries.

Novo Nordisk has 15 subsidiaries including Dicerna Pharmaceuticals, NNE Pharmaplan and NNIT.

They are in:

• Pharmaceuticals75%
• Biotechnology6%
• Other19%

Acquisition, funding and merger involving Novo Nordisk.

• Novo Nordisk has announced the acquisition of Emisphere Technologies  (posted on November 10 2020).
• Novo Nordisk has announced the acquisition of Dicerna Pharmaceuticals  (posted on November 19 2021).

View the org chart displaying its 2 main executives

Most searched biographies at Novo Nordisk Russia

• Hans Duijf, Vice President and General Manager
• Natalia Kovalenko, General Manager, Rising Markets

Create an alert
to follow the executive moves at Novo Nordisk Russia.

Novo Nordisk has 1,993 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland).

Popular M&A news in Pharmaceuticals

• Regeneron Pharmaceuticals has announced the acquisition of Checkmate Pharmaceuticals  (posted on May 31 2022).
• Zentalis Pharmaceuticals has just announced a $200 Million fundraising. (posted on May 19 2022).
• Pfizer has announced the acquisition of Biohaven Pharmaceutical  (posted on May 12 2022).

Popular contacts in Pharmaceuticals

• Richard Gonzalez - Chairman and Chief Executive Officer at AbbVie
• Joaquin Duato - Chief Executive Officer and Director at Johnson & Johnson
• Keith Goldan - Chief Financial Officer at Syndax Pharmaceuticals

Learn more about the Pharmaceuticals industry >

Press releases by Novo Nordisk Russia

Social media about Novo Nordisk Russia

• Novo Nordisk Russia on Wikipedia, Google News & Yahoo Finance
• Novo Nordisk Russia on LinkedIn, Twitter & YouTube

Call Novo Nordisk Russia at +7 495...

View the org chart

Register to receive your alert

Report an error